Summary
Garrod's important second book,Inborn Factors in Disease (1931), was about inherited predisposition to disease. Chemical and metabolic individuality, which are the modalities of predisposition, originated in ‘molecular groupings’ (proteins) in Garrod's view of life. Such ‘groupings’ as interlocus molecular hybrids, allelic complementation and expressions of modifier genes, can assume variant expression in heterozygotes. Here, it is shown that genetic variation in such ‘molecular groupings’ has clinical relevance, for example (1) in reproductive counselling for thalassaemia; (2) in heterozygosity where the affected enzymes are normally homopolymeric; (3) in clinical severity of ‘monogenic’ disease (e.g. familial hypercholesterolaemia and muscular dystrophy) when variation is not explained by allelic heterogeneity. The associated chemical individuality in each case can be used to identify risk and thus as a mode of predictive medicine.
Similar content being viewed by others
References
Akerman, B. Molecular studies of the alpha globin gene in Quebec populations.MSc Thesis, McGill University, 1987
Akerman, B. R., Lancaster, G. A. and Scriver, C. R. Alpha-thalassemia mutations are common in Quebec populations and they modify β-thalassemia gene expression.Am. J. Hum. Genet. (1987) A93
Aula, P., Nänto, V., Laipio, M.-L. and Autio, S. Aspartylglucosaminuria: deficiency of aspartylglucosaminidase in cultured fibroblasts of patients and their heterozygous parents.Clin. Genet. 4 (1973) 297
Bartholomé, K. Genetics and biochemistry of the phenylketonuria — present state.Hum. Genet. 51 (1979) 241–245
Bartholomé, K. and Dresel, A. Studies on the molecular defect in phenylketonuria and hyperphenylalaninemia using antibodies against phenylalanine hydroxylase.J. Inher. Metab. Dis. 5 (1982) 7–10
Beadle, G. W. Genes and chemical reactions in neurospora.Science 129 (1959) 1715–1719
Bearn, A. G. and Miller, E. D. Archibald Garrod and the development of the concept of inborn errors of metabolism.Bull. Hist. Med. 53 (1979) 315–328
Boright, A. P. Studies of prolidase deficiency in cultured skin fibroblasts.Doctoral Thesis, McGill University, 1988
Boright, A. P., Lancaster, G. A. and Scriver, C. R. A classification of rare alleles causing prolidase deficiency.Am. J. Hum. Genet. (1988) A3
Brown, M. S. and Goldstein, J. L. A receptor-mediated pathway for cholesterol homeostasis.Science 232 (1986) 34–47
Burgio, G. R. ‘Inborn errors of metabolism’ and ‘chemical individuality’, two ideas of Sir Archibald Garrod briefly revisited 50 years after his death.Eur. J. Pediatr. 145 (1986) 2–5
Childs, B. Sir Archibald Garrod's conception of chemical individuality: a modern appreciation.N. Engl. J. Med. 282 (1970) 71–77
Childs, B. Implications for disease of Sir Archibald Garrod's views on chemical individuality. In Wapnir, R. A. (ed.)Congenital Metabolic Diseases Diagnosis and Treatment, Marcel Dekker Inc., New York, 1985, pp. 3–11
Childs, B. Introduction to molecular genetics in medicine.Progr. Med. Genet. (new series) 7 (1988) 1–16
Childs, B. and Scriver, C. R. Age at onset and causes of disease.Perspect. Biol. Med. 29 (1986) 437–460
Christensen, E. and Brandt, N. J. Studies on glutaryl-CoA dehydrogenase in leucocytes, fibroblasts and amniotic fluid cells. The normal enzyme and the mutant form in patients with glutaric aciduria.Clin. Chim. Acta. 88 (1978) 267–276
Cooper, B. J., Winand, N. J., Stedman, H., Valentine, B. A., Hoffman, E. P., Kunkel, L. M., Scott, M.-O., Fischbeck, K. H., Kornegay, J. N., Avery, R. J., Williams, J. R., Schmickel, R. D. and Sylvester, J. E. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs.Nature (London) 334 (1988) 154–156
Danks, D. M., Schlesinger, R., Firgaira, F., Cotton, R. G. H., Watson, B. M., Rembold, H. and Hennings, G. Malignant hyperphenylalaninemia — clinical features, biochemical findings, and experience with administration of biopterins.Pediatr. Res. 13 (1979) 1150–1155
De Braekeleer, M., Morgan, K., Jomphe, M., Buchard, G., Davignon, J., Kessling, A., Laberge, C., Moorjani, S., Roy, M. and Scriver, C. R. Familial hypercholesterolemia in French-Canadians: geographical distribution and centre of origin of an LDL-receptor deletion mutation.SOREP (Univ. du Qué, à Chicoutimi) (Document No. III-C-60 Oct.), 1988
Firgaira, F. A., Cotton, R. G. H. and Danks, D. M. Dihydropteridine reductase deficiency diagnosis by assay on peripheral blood-cells.Lancet 2 (1979) 1260–1263
Fleisher, L. D., Tallan, H. H., Bertis, H. G., Hirschhorn, K. and Gaull, G. E. Cystathionine synthase deficiency: heterozygote detection using cultured skin fibroblasts.Biochem. Biophys. Res. Comun. 55 (1973) 38–43
Garrod, A. E.Inborn Errors of Metabolism: The Croonian Lectures delivered before the Royal College of Physicians of London in June 1908. Frowde; Hodder and Stoughton, London, 1909
Garrod, A. E. The Huxley Lecture on diathesis.Lancet 2 (1927) 1113–1118
Garrod, A. E.The Inborn Factors in Disease, Oxford at the Clarendon Press, 1931
Gibson, K. M., Sweetman, L., Nyhan, W. L., Jansen, I. and Jaeken, J. Demonstration of 4-aminobutyric acid aminotransferase deficiency in lymphocytes and lymphoblasts.J. Inher. Metab. Dis. 8 (1985) 204–208
Goldstein, J. L., Hazzard, W. R., Schrott, H. G., Bierman, E. L., Motulsky, A. G., Levinski, M. J. and Campbell, E. D. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction.J. Clin. Invest. 52 (1973) 1533–1543
Goodman, S. I. and Kohlhoff, J. G. Glutaric aciduria: inherited deficiency of glutaryl-CoA dehydrogenase activity.Biochem. Med. 13 (1975) 138–140
Grimm, U., Knapp, A., Schlenzka, K. and Hesse, R. Phenylalaninhydroxylase-aktivatät beiheterozygoten Anlageträgern für das Phenylketonurie-Gen.Acta Biol. Med. Germ. 36 (1977) 1179–1182
Harris, H.The Principles of Human Biochemical Genetics, 3rd edn, rev., Elsevier, New York, 1980, pp. 246–256
Harris, H., Hopkinson, D. A. and Edwards, Y. H. Polymorphism and the subunit structure of enzymes: a contribution to the neutralist selectionist controversy.Proc. Natl. Acad. Sci. USA 74 (1977) 697–701
Herskowitz, I. Functional inactivation of genes by dominant negative mutations.Nature (London) 329 (1987) 219–222
Hobbs, H. H., Brown, M. S., Russell, D. W., Davignon, J. and Goldstein, J. L. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia.N. Engl. J. Med. 317 (1987) 734–737
Hopkins, F. G. Obituary — Sir Archibald Garrod.Br. Med. J. 1 (1936a) 775–776
Hopkins, F. G. Sir Archibald Garrod, KCMG, FRS.Nature (London) May 9 (1936b) 770–771
Hopkins, F. G. Obituaries of A. E. Garrod.The Royal Society (Obituary Notices) 2 (1938) 225–228
Johnson, W. G. Metabolic interference and the +-heterozygote. A hypothetical form of simple inheritance which is neither dominant nor recessive.Am. J. Hum. Genet. 32 (1980) 374–386
Jomphe, M., Bouchard, G., Davignon, J., De Braekeleer, M., Gradie, M., Kessling, A., Laberge, C., Moorjani, S., Morgan, K., Roy, M. and Scriver, C. R. Familial hypercholesterolemia in French-Canadians: geographical distribution and centre of origin of an LDL-receptor deletion mutation.Am. J. Hum. Genet. 43 (1988) A216
Kacser, H. and Burns, J. A. The molecular basis of dominance.Genetics 97 (1981) 639–666
Kanavakis, E., Wainscoat, J. S., Wood, W. G., Weatherall, D. J., Cao, A., Furbeta, M., Galanello, R., Georgiou, D. and Sophocleous, T. The interaction of α thalassemia with heterozygous β thalassemia.Br. J. Haematal. 52 (1982) 465
Kaplan, F., Akerman, B., Bardanis, M. and Scriver, C. R. The β-globin gene, a β-thalassemia allele and associated RFLP haplotypes in French-Canadians.Am. J. Hum. Genet. 43 (1988) A216
Kaufman, S., Max, E. E. and Kang, E. S. Phenylalanine hydroxylase activity in liver biopsies from hyperphenylalaninemia heterozygotes: deviation from proportionality with gene dosage.Pediatr. Res. 9 (1975) 632–634
King, L. S.Medical Thinking. A Historial Preface, Princeton University Press, Princeton, 1982, pp. 187–203
Lane, A. B. and Jenkins, T. Two variant hexosaminidase β-chain alleles segregating in a South African family.Clin. Chim. Acta 87 (1978) 219–228
Langenbeck, U., Lukas, H. D., Mench-Hoinowski, A., Stenzig, K. P. and Lane, J. D. Correlative study of mental and biochemical phenotypes in never treated patients with classic phenylketonuria.Brain Dysfunction 1 (1988) 103–110
Lowden, J. A. Evidence for a hybrid hexosaminidase isoenzyme in heterozygotes for Sandhoff disease.Am. J. Hum. Genet. 31 (1979) 281–289
Malhotra, S. B., Hart, K. A., Klamut, H. J., Thomas, S. T., Bodrug, S. E., Burghes, A. H. M., Bobrow, M., Harper, P. S., Thompson, M. W., Ray, P. N. and Worton, R. G. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy.Science 242 (1988) 755–759
Mayr, E.The Growth of Biological Thought. Harvard University Press, Cambridge, MA, 1982, pp. 63–64
Milstien, S., Holtzman, N. A., O'Flynn, M. E., Thomas, G. H., Butler, I. J. and Kaufman, S. Hyperphenylalaninemia due to dihydropteridine reductase deficiency.J. Pediatr. 89 (1976) 763–766
Moorjani, S., Roy, M., Gagné, C., Davignon, J., Brun, D., Toussaint, M., Lambert, M., Campeau, L., Blaichman, S. and Lupien, P. Homozygous familial hypercholesterolemia among French Canadians in Province of Quebec.Arteriosclerosis (1989) in press
Murphy, E. A. and Pyeritz, R. E. Homeostasis. VII. A conspectus.Am. J. Med. Genet. 24 (1986) 735–751
Needham, J. Frederick Gowland Hopkins.Perspect. Biol. Med. 6 (1962) 2–46
Ponzone, A., Guardamagna, O., Ferraris, S., Bracco, G., Niederwieser, A. and Cotton, R. G. M. The mutations of dihydropteridine reductase deficiency.Arch. Dis. Child. 63 (1988) 154–157
Prévost, C., Laframboise, R., Bardanis, M., Clow, C., Lancaster, G., Desjardins, L., Cantin, F. and Scriver, C. R. Le gène de la β-thalassémie au Canada français: relance dans le comté de Portneuf.L'Union Méd. du Can. 18 (1988) 141–144
Rosatelli, C., Falchi, A. M., Scalas, M. T., Tuveri, T., Furbetta, M. and Cao, A. Hematological phenotype of double heterozygous state for alpha and beta thalassemia.Hemoglobin 8 (1984) 25
Rose, G. Sick individuals and sick populations.Int. J. Epidemiol. 14 (1985) 32–38
Salter, M., Knowles, R. G. and Pogson, C. I. Quantification of the importance of individual steps in the control of aromatic amino acid metabolism.Biochem. J. 234 (1986) 635–647
Scriver, C. R. Window panes of eternity. Health, disease, and inherited risk.Yale J. Biol. Med. 55 (1982a) 487–513
Scriver, C. R. Screening for medical intervention: the PKU experience. In Human Genetics, Part B. Medical aspects.Prog. Clin. Biol. Res. 103B (1982b) 437–445
Scriver, C. R. The Canadian Rutherford lecture: an evolutionary view of disease in man.Proc. R. Soc. Lond. B. 220 (1984) 273–298
Scriver, C. R. Inborn errors of metabolic homeostasis: Garrod's message revisited. In Wapnir, R. A. (ed.)Congenital Metabolic Diseases and Treatment, Marcel Dekker, New York, 1985, pp. 11–40
Scriver, C. R. Presidential Address: Physiological genetics — Who needs it?Am. J. Hum. Genet. 40 (1987) 199–211
Scriver, C. R. and Childs, B.Garrod's Inborn Factors in Disease, Oxford Monographs in Medical Genetics, 16, Oxford University Press, Oxford, 1989
Scriver, C. R. and Rosenberg, L. E.Amino Acid Metabolism and its Disorders, Saunders, Philadelphia, 1973, pp. 290–337
Scriver, C. R., Bardanis, M., Cartier, L., Clow, C. L., Lancaster, G. A. and Ostrowsky, J. T. β-thalassemia disease prevention: genetic medicine applied.Am. J. Hum. Genet. 36 (1984) 1024–1038
Scriver, C. R., Gregory, D. M., Sovetts, D. and Tissenbaum, G. Normal plasma free amino acid values in adults: the influence of some common physiological variables.Metabolism 34 (1985) 868–873
Scriver, C. R., Clow, C. L., Kaplan, P. and Niederwieser, A. Hyperphenylalaninemia due to deficiency of 6-pyruvoyl tetrahydropterin synthase. Unusual gene dosage effect in heterozygotes.Hum. Genet. 77 (1987a) 168–171
Scriver, C. R., Mahon, B., Levy, H. L., Clow, C. L., Reade, T. M., Kronick, J., Lemieux, B. and Laberge, C. The Hartnup phenotype: Mendelian transport disorder, multifactorial disease.Am. J. Hum. Genet. 40 (1987b) 401–412
Sober, E.The Nature of Selection. Evolutionary Theory in Philosophical Focus, MIT Press, Cambridge, MA, 1984, pp. 278–281
Takikawa, S.-I., Curtius, H.-C., Redweik, U., Leimbacher, W. and Ghisla, S. Biosynthesis of tetrahydrobiopterin. Purification and characterization of 6-pyruvoyl tetrahydropterin synthase from human liver.Eur. J. Biochem. 161 (1986) 296–302
Vogel, F. Clinical consequences of heterozygosity for autosomal-recessive diseases.Clin. Genet. 25 (1984) 381–415
Weatherall, D. J., Clegg, J. B., Higgs, D. R. and Wood, W. G. The hemoglobinopathies. In Scriver, C. R., Beaudet, A., Sly, W. L. and Valle, D. (eds.)The Metabolic Basis of Inherited Disease, 6th edition, McGraw Hill Book Co., New York, 1989, pp. 2281–2340
Whelan, D. T., Hill, R., Ryan, E. D. and Spate, M.l-glutaric acidemia: investigation of a patient and his family.Pediatrics 63 (1979) 88–93
Williams, R. J. Biochemical individuality. The basis for the genetotrophic concept.Science Edition. J. Wiley and Son, New York, 1963
Zannis-Hadjopoulos, M., Gold, R. J. M., Maag, U. R., Metrakos, J. D. and Scriver, C. R. Improved detection of β-thalassemia carriers by a two-test method.Hum. Genet 38 (1977) 315–324
Author information
Authors and Affiliations
Additional information
From a talk delivered, while I was President, to the 26th Annual Meeting of the Society for the Study of Inborn Errors of Metabolism.
Rights and permissions
About this article
Cite this article
Scriver, C.R. The salience of Garrod's ‘molecular groupings’ and ‘Inborn Factors in Disease’. J Inherit Metab Dis 12 (Suppl 1), 9–24 (1989). https://doi.org/10.1007/BF01799283
Issue Date:
DOI: https://doi.org/10.1007/BF01799283